Lovejoy Chandra D 4
4 · ENDOCYTE INC · Filed Feb 26, 2013
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Lovejoy Chandra D
VP of Regulatory Affairs
Transactions
- Sale
Common Stock
2013-02-25$9.70/sh−1,993$19,332→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2013-02-25−1,993→ 6,609 totalExercise: $3.05Exp: 2017-11-14→ Common Stock (1,993 underlying) - Exercise/Conversion
Common Stock
2013-02-25$2.54/sh+109$277→ 109 total - Sale
Common Stock
2013-02-25$9.70/sh−109$1,057→ 0 total - Exercise/Conversion
Common Stock
2013-02-25$3.05/sh+1,993$6,079→ 1,993 total - Exercise/Conversion
Stock Option (right to buy)
2013-02-25−109→ 655 totalExercise: $2.54Exp: 2019-08-13→ Common Stock (109 underlying)
Footnotes (3)
- [F1]The shares were sold pursuant to a written plan as specified in Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Shares subject to vest monthly over a period of 48 months beginning on August 31, 2009.
- [F3]Shares subject to vest 50% on November 14, 2009 and monthly over a period of 24 months beginning on November 30, 2009.